The Analyst Landscape: 4 Takes On Inovio Pharmaceuticals

分析师视角：对伊诺维奥制药的4种看法

Benzinga · 2024/11/19 04:01

Analysts' ratings for Inovio Pharmaceuticals (NASDAQ:INO) over the last quarter vary from bullish to bearish, as provided by 4 analysts.

在过去的一个季度中，4位分析师对伊诺维奥制药（纳斯达克：INO）的评级从看好到看淡不等。

The table below provides a concise overview of recent ratings by analysts, offering insights into the changing sentiments over the past 30 days and drawing comparisons with the preceding months for a holistic perspective.

下表提供了分析师最近的评级概述，为了全面了解过去30天的情绪变化并与前几个月进行比较，提供了深入的见解。

Insights from analysts' 12-month price targets are revealed, presenting an average target of $8.25, a high estimate of $15.00, and a low estimate of $5.00. A decline of 45.0% from the prior average price target is evident in the current average.

分析师的12个月价格目标洞察被披露，呈现出平均目标为8.25美元，最高估计为15.00美元，最低估计为5.00美元。当前平均价格目标显示出较之前平均价格目标下降了45.0%。

Interpreting Analyst Ratings: A Closer Look

解读分析师评级：更深入的了解

A comprehensive examination of...

关于金融...

登录免费看全文

声明：本内容仅用作提供资讯及教育之目的，不构成对任何特定投资或投资策略的推荐或认可。更多信息

The Analyst Landscape: 4 Takes On Inovio Pharmaceuticals

The Analyst Landscape: 4 Takes On Inovio Pharmaceuticals

风险及免责提示

声明